News

The study recruited and dosed people who did not benefit from the use of at least two currently available medicines for partial epilepsy. In the study, the patients

In future, Biothera is planning to conduct trials with the combination therapy of Imprime PGG and AS1402. Imprime PGG is a new immunotherapy that works synergistically with anti-tumor

Brenntag markets a diversified line of specialty and industrial chemicals for a variety of applications, including personal care, coatings, food & beverage, pharmaceuticals, textile, rubber, plastics & polymers,

In the study, 48 patients were evaluated with 0.1%w/w CT327 cream twice daily and nine patients treated with matching placebo. The study results suggested that CT327produced a good

The Knowledge Centre was opened to support Grace’s customers in the areas of laboratory separations, bulk purification, excipients and pharmaceutical intermediates. Grace’s expertise in the areas assists pharmaceutical

The funding will be used for the pre-clinical development of a novel vaccine to prevent meningitis B infection in children. Action Medical Research senior research evaluation manager Dr

The initial aim of the collaboration is to pursue a comprehensive and systematic approach to identify and develop physiological mechanisms and targets that regulate beta cell replication. Evotec

The open-labeled trial (GRASPALL-GRAALL SA2 2008) introduced GRASPA in a first-line treatment for Acute Lymphoblastic Leukemia (ALL) in patients older than 55 years. The clinical end point combines

Tris Pharma said if the drug will be approved by the FDA its extended release suspension will offer an alternative to the currently available immediate release formulations. The